Open Access

Poster session 3 - Intravascular imaging and physiology

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Poster Session
Date: 28 August 2016

Session

19 presentations in this session

Nanoparticle visualization by clinical intracoronary optical coherence tomography.

Speaker: Doctor F. Rivero (Madrid, ES)
Thumbnail

Early effects of intensive lipid-lowering treatment on plaque characteristics assessed by virtual histology intravascular ultrasound

Speaker: Assistant Professor J. Lee (Daegu, KR)
Thumbnail

Intracoronary nicorandil as an adjunctive hyperemic agent during FFR measurements

Speaker: Professor H. Okura (Gifu, JP)
Thumbnail

Comparison of outcomes between intravascular ultrasound and optical coherence tomography-assisted percutaneous coronary intervention

Speaker: Professor T. Hong (Busan, KR)
Thumbnail

Relation between Instantaneous Wave-Free Ratio and Fractional Flow Reserve in Patients with Hemodialysis

Speaker: Doctor Y. Morioka (Tokyo, JP)
Thumbnail

Prediction of periprocedural myocardial infarction following percutaneous coronary intervention by multimodal imaging of gray-scale, iMap-intravascular ultrasound, and optical coherence tomography

Speaker: Doctor S. Koga (Tokyo, JP)
Thumbnail

Coronary vasa vasorum in grayscale intravascular ultrasound had high plaque vulnerability and frequent no-reflow phenomenon during percutaneous coronary intervention

Speaker: Associate Professor H. Amano (Tokyo, JP)
Thumbnail

Relevance of optical coherence tomography-derived morphological and anatomical features in accordance with hemodynamic significance determined by fractional flow reserve

Speaker: Doctor E. Usui (Tsuchiura, JP)
Thumbnail

Intravascular ultrasound guidance is associated with lower mortality in patients undergoing stenting for unprotected left main coronary artery lesions compared to angiography-guided stent implantation

Speaker: Doctor P. Andell (Lund, SE)
Thumbnail

Efficiency of optical frequency domain imaging in identifying functionally significant coronary stenosis as determined by fractional flow reserve according to vessel diameter

Speaker: Doctor N. Kogame (Amsterdam, NL)
Thumbnail

19 speakers from this session

Doctor Fernando Rivero

University Hospital De La Princesa, Madrid (Spain)
0 follower

Assistant Professor Jung-Hee Lee

Yeungnam University Hospital, Daegu (Korea (Republic of))
0 follower

Professor Hiroyuki Okura

Gifu University Graduate School of Medicine, Gifu (Japan)
2 presentations
0 follower

Professor Taek Jong Hong

Pusan National University Hospital, Busan (Korea (Republic of))
0 follower

Doctor Yuta Morioka

Tokyo Women's Medical University, Tokyo (Japan)
0 follower

Doctor Seiji Koga

Juntendo University Nerima Hospital, Tokyo (Japan)
0 follower

Associate Professor Hideo Amano

Toho University Graduate School of Medicine, Tokyo (Japan)
0 follower

Doctor Eisuke Usui

Tsuchiura Kyodo Hospital, Tsuchiura (Japan)
0 follower

Doctor Pontus Andell

Lund University, Skane University Hospital, Department of Cardiology, Lund (Sweden)
0 follower

Doctor Norihiro Kogame

AMC Medical Research BV, Amsterdam (Netherlands (The))
0 follower

Doctor Tatsuya Nunohiro

Nagasaki Harbor Medical Center, Nagasaki (Japan)
0 follower

Doctor Masato Ishikawa

Fujita Health University Hospital, Toyoake (Japan)
0 follower

Doctor Tomoyo Sugiyama

Tsuchiura Kyodo General Hospital, Tsuchiura (Japan)
0 follower

Doctor Khalil Houissa

Université de Mons - Faculté de Médecine et de Pharmacie, Mons (Belgium)
0 follower

Doctor Mahmoud Mohamed Hassan Sabbah

Suez Canal University, Department of Cardiology, Ismailia (Egypt)
0 follower

Doctor Evgeniy Kretov

State Research Institute of Circulation Pathology, Novosibirsk (Russian Federation)
0 follower

Mr Yuichi Saito

Chiba University Graduate School of Medicine, Chiba (Japan)
0 follower

Associate Professor Hisao Otsuki

Tokyo Women's Medical University, Department of Cardiology, Tokyo (Japan)
0 follower

Doctor Maoto Habara

Toyohashi Heart Center, Toyohashi (Japan)
0 follower

This platform is supported by

logo Novo Nordisk